Recently, Suzhou Wushuang Medical Equipment Co., Ltd. (hereinafter referred to as “Wushuang Medical”) announced the completion of a B+ round of financing of hundreds of millions of yuan. This round of financing was invested by institutions such as Hetang Venture Capital and Kangyu Capital, and the existing shareholder Qiming Venture Capital continued to support it. The funds raised in this round of financing will be used for clinical trial advancement, product pipeline expansion, and marketing team building.
Founded in 2017, Wushuang Medical is the only high-tech medical device company in China with a heart rhythm and heart failure treatment technology platform with independent intellectual property rights. Wushuang Medical is headquartered in Suzhou High-tech Zone Medical Device Industrial Park. It has R&D centers in Beijing and California, USA, and a key process R&D and small-batch production center in Minnesota, USA.
media reports
Arterial Network Arterial Network Investment Group invested in China Network Yiou Entrepreneurship
Event Tracking
- 2023-01-06 Wushuang Medical completed hundreds of millions of yuan in B+ round financing
- 2020-03-17 Independent research and development of domestic ICD, Wushuang Medical received tens of millions of US dollars in Series A financing
This article is transferred from: https://readhub.cn/topic/8mlyfaP2ZbW
This site is only for collection, and the copyright belongs to the original author.